A global cannabis company serving both the medical and consumer markets is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of ...

Explore why the Curaleaf stock price has crashed and what to expect in the coming months now that it has formed inverse C&H ...

What is the outlook of the Tilray stock price after crashing below $1? We explain what to expect and whether it is a good ...